A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
A Study to Assess Safety and Preliminary Efficacy of LP-108 Combined With Azacitidine In Subjects With AML, MDS, CMML
- Status
- RECRUITING
- Phase
- PHASE1
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
- Status
- RECRUITING
- Phase
- PHASE1
CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome
- Status
- SUSPENDED
- Phase
- PHASE2
A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics
- Status
- TERMINATED
- Phase
- PHASE1
First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS
- Status
- AVAILABLE
- Phase
- N/A
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
- Status
- RECRUITING
- Phase
- N/A
Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study to Evaluate Imetelstat in Patients With High-Risk MDS or AML Failing HMA-based Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
- Status
- RECRUITING
- Phase
- PHASE1
Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Compassionate Communication and Advance Care Planning to Improve End of Life Care in Treatment of Hematological Disease (ACT)
- Status
- RECRUITING
- Phase
- NA
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
- Status
- RECRUITING
- Phase
- NA
Lifestyle-modifying Interventions in Low-risk MDS Patients
- Status
- NOT_YET_RECRUITING
- Phase
- NA